| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/2011 | US20110030077 METHODS OF MODULATING THE ORGANIC SOLUTE AND STEROID TRANSPORTER (OSTalpha-OSTbeta) ACTIVITY AND TREATING ASSOCIATED CONDITIONS |
| 02/03/2011 | US20110030075 Methods and Compositions Capable of Causing Post-Transcriptional Silencing of Gene Expression in a Synergic Manner |
| 02/03/2011 | US20110028807 Contact lens for collecting tears and detecting at least one analyte |
| 02/03/2011 | US20110028714 Folate mimetics and folate-receptor binding conjugates thereof |
| 02/03/2011 | US20110028711 Unsaturated Steroid Compounds |
| 02/03/2011 | US20110028567 Smooth muscle contraction inhibitors |
| 02/03/2011 | US20110028566 Compositions and products containing cycloaliphatic diol antimicrobial agents and methods of using the compositions and products |
| 02/03/2011 | US20110028565 Exo-s-mecamylamine formulation and use in treatment |
| 02/03/2011 | US20110028564 Compositions and methods for treatment of filovirus-mediated diseases |
| 02/03/2011 | US20110028563 Anti-microbial composition |
| 02/03/2011 | US20110028562 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use |
| 02/03/2011 | US20110028561 Protection of neural retina by reduction of rod metabolism |
| 02/03/2011 | US20110028560 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock |
| 02/03/2011 | US20110028559 Substituted fluoroethyl ureas as alpha 2 adrenergic agents |
| 02/03/2011 | US20110028558 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | US20110028557 Treating patients with intravenous ibuprofen |
| 02/03/2011 | US20110028556 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | US20110028555 Antiinflammatory and Analgesic Preparation for External Use |
| 02/03/2011 | US20110028554 pharmaceutical compositions comprising diiodothyronine and their therapeutic use |
| 02/03/2011 | US20110028553 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | US20110028552 Mexiletine amino acid and peptide prodrugs and uses thereof |
| 02/03/2011 | US20110028551 Novel process for the preparation of sodium gamma-hydroxybutyrate |
| 02/03/2011 | US20110028549 Use of a monoterpene to treat or prevent stress |
| 02/03/2011 | US20110028548 Beneficial effects of increasing local blood flow |
| 02/03/2011 | US20110028547 Novel use of capsiate or dihydrocapsidate |
| 02/03/2011 | US20110028544 Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| 02/03/2011 | US20110028543 Formulations and methods of using nitric oxide mimetics in cancer treatment |
| 02/03/2011 | US20110028542 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| 02/03/2011 | US20110028541 Lubiprostone crystal, the use and the method for the preparation thereof |
| 02/03/2011 | US20110028540 Synthesis of macrocyclic cancer chemotherapy agents and methods of use |
| 02/03/2011 | US20110028539 Biologically active taxane analogs and methods of treatment |
| 02/03/2011 | US20110028538 Methods and compositions related to tr4 ligand |
| 02/03/2011 | US20110028536 Methods and compositions for topoisomerase i modulated tumor suppression |
| 02/03/2011 | US20110028535 Oligonucleotides-transferring preparations |
| 02/03/2011 | US20110028534 RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS |
| 02/03/2011 | US20110028533 Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 02/03/2011 | US20110028532 Methods of treating eye diseases in diabetic patients |
| 02/03/2011 | US20110028531 Novel sirna compounds for inhibiting rtp801 |
| 02/03/2011 | US20110028530 Novel crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid 471 |
| 02/03/2011 | US20110028529 Novel crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid 471 |
| 02/03/2011 | US20110028527 Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgamma |
| 02/03/2011 | US20110028526 Valsartan solid oral dosage forms and methods of making such formulations |
| 02/03/2011 | US20110028524 Pharmaceutical compositions for poorly soluble drugs |
| 02/03/2011 | US20110028523 Selective Alpha 2B/2C Agonists |
| 02/03/2011 | US20110028522 Fullerene therapies for inflammation |
| 02/03/2011 | US20110028520 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 02/03/2011 | US20110028519 Small molecule insulin mimetics absent quinones |
| 02/03/2011 | US20110028518 Dexlansoprazole process and polymorphs |
| 02/03/2011 | US20110028517 4-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as a cannabinoid cb1 neutral antagonist |
| 02/03/2011 | US20110028516 Stabilized and preserved ketoifen ophthalmic compositions |
| 02/03/2011 | US20110028515 New piperidine derivatives |
| 02/03/2011 | US20110028514 Azoles as Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 02/03/2011 | US20110028513 Method for treating neurological disorders with imidazolium and imidazolinium compounds |
| 02/03/2011 | US20110028512 Bis-heterocyclic imidazolyl compounds |
| 02/03/2011 | US20110028511 Process for the manufacture of pharmaceutically active compounds |
| 02/03/2011 | US20110028510 Compositions, Methods, and Kits for Treating Influenza Viral Infections |
| 02/03/2011 | US20110028509 Sulfonamides |
| 02/03/2011 | US20110028508 Novel process for the preparation of scopine esters |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028506 Pharmaceutical Composition For Preventintion And Treatment Of Restenosis Comprising Isoxazole Derivatives |
| 02/03/2011 | US20110028505 Compositions and methods for reducing food cravings |
| 02/03/2011 | US20110028504 Formulation of radioprotective alpha beta unsaturated aryl sulfones |
| 02/03/2011 | US20110028503 Compositions and methods for inhibition of the jak pathway |
| 02/03/2011 | US20110028502 Dihydropyrimidone amides as p2x7 modulators |
| 02/03/2011 | US20110028501 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/03/2011 | US20110028500 Plant pathogen inhibitor combinations and methods of use |
| 02/03/2011 | US20110028499 Pharmaceutical combination comprising vitamin k |
| 02/03/2011 | US20110028498 Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinase |
| 02/03/2011 | US20110028497 Novel derivatives of purinic and pyrimidinic antiviral agents and use thereof as potent anticancer agents |
| 02/03/2011 | US20110028496 Deuterium-enriched pyrimidine compounds and derivatives |
| 02/03/2011 | US20110028495 THE USE OF 6-HALOGENO-[1,2,4]-TRIAZOLO-[1,5-a]-PYRIMIDINE COMPOUNDS FOR COMBATING PESTS IN AND ON ANIMALS |
| 02/03/2011 | US20110028494 HCV NS3 Protease Inhibitors |
| 02/03/2011 | US20110028493 Heterocyclic derivative and use thereof |
| 02/03/2011 | US20110028492 Heteroaryl Compounds and Their Uses |
| 02/03/2011 | US20110028491 Apoptosis inhibitor |
| 02/03/2011 | US20110028490 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake in-hibitors |
| 02/03/2011 | US20110028489 Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders |
| 02/03/2011 | US20110028488 Combination product comprising src kinase inhibitor azdo530 and an antioestrogen or egfr-tk-inhibitor |
| 02/03/2011 | US20110028487 Imidazopyrimidines and uses thereof |
| 02/03/2011 | US20110028486 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7 |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028484 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
| 02/03/2011 | US20110028483 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 02/03/2011 | US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028481 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/03/2011 | US20110028480 Orodispersable formulations of phosphodiesterase-5 (pde-5) inhibitors |
| 02/03/2011 | US20110028479 Substituted pyrrolotriazines and their use |
| 02/03/2011 | US20110028478 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028477 Stable ophthalmic formulations |
| 02/03/2011 | US20110028476 Proton pump inhibitors |
| 02/03/2011 | US20110028475 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 02/03/2011 | US20110028474 Protein kinase and phosphatase inhibitors |
| 02/03/2011 | US20110028473 Methods of treating drug resistant and other tumors by administering 6,7-dialkoxy quinazoline derivatives |
| 02/03/2011 | US20110028472 Thienopyrimidines |
| 02/03/2011 | US20110028471 Combination therapy 238 |
| 02/03/2011 | US20110028470 Detection and Treatment of Schizophrenia |
| 02/03/2011 | US20110028469 Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor |
| 02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
| 02/03/2011 | US20110028467 Heterocyclic derivatives |
| 02/03/2011 | US20110028466 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses |